These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23460659)

  • 21. Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research Database.
    Sazonov V; Beetsch J; Phatak H; Wentworth C; Evans M
    Atherosclerosis; 2010 Jan; 208(1):210-6. PubMed ID: 19766999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-high-density lipoprotein cholesterol: an important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patients.
    Araki A; Iimuro S; Sakurai T; Umegaki H; Iijima K; Nakano H; Oba K; Yokono K; Sone H; Yamada N; Ako J; Kozaki K; Miura H; Kashiwagi A; Kikkawa R; Yoshimura Y; Nakano T; Ohashi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():18-28. PubMed ID: 22435937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.
    Deedwania PC; Pedersen TR; DeMicco DA; Breazna A; Betteridge DJ; Hitman GA; Durrington P; Neil A;
    Int J Cardiol; 2016 Nov; 222():548-556. PubMed ID: 27513651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
    Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
    Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus.
    Nichols GA; Vupputuri S; Rosales AG
    Am J Cardiol; 2011 Oct; 108(8):1124-8. PubMed ID: 21985949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.
    Waters DD; LaRosa JC; Barter P; Fruchart JC; Gotto AM; Carter R; Breazna A; Kastelein JJ; Grundy SM
    J Am Coll Cardiol; 2006 Nov; 48(9):1793-9. PubMed ID: 17084252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
    Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.
    Ambegaonkar BM; Bash LD; Chirovsky DR; Jameson K; Grant S; Nocea G; Pettersson B; Sazonov V
    Eur J Intern Med; 2013 Oct; 24(7):656-63. PubMed ID: 23953848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very high risk of cardiovascular events in the United Kingdom: a cross-sectional study.
    Danese MD; Sidelnikov E; Kutikova L
    Curr Med Res Opin; 2018 Aug; 34(8):1441-1447. PubMed ID: 29627994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ohashi Y; Akanuma Y; Yamada N;
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3448-56. PubMed ID: 21865372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets.
    Toth PP; Grabner M; Punekar RS; Quimbo RA; Cziraky MJ; Jacobson TA
    Atherosclerosis; 2014 Aug; 235(2):585-91. PubMed ID: 24956532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
    van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
    Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction.
    Mahajan N; Ference BA; Arora N; Madhavan R; Bhattacharya P; Sudhakar R; Sagar A; Wang Y; Sacks F; Afonso L
    Am J Cardiol; 2012 Jun; 109(12):1694-9. PubMed ID: 22465317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-density lipoprotein cholesterol levels in adults with type 2 diabetes: an alternative equation for accurate estimation and improved cardiovascular risk classification.
    Chai Kheng EY; Chee Fang S; Chang S; Kiat Mun SL; Su Chi L; Lee Ying Y; Xiao Wei N; Wern Ee T; Biing Ming SL; Tavintharan S
    Diab Vasc Dis Res; 2014 Nov; 11(6):431-9. PubMed ID: 25205607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.
    Bangalore S; Breazna A; DeMicco DA; Wun CC; Messerli FH;
    J Am Coll Cardiol; 2015 Apr; 65(15):1539-48. PubMed ID: 25881936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study.
    Wu J; Chen S; Liu L; Gao X; Zhou Y; Wang C; Zhang Q; Wang A; Hussain M; Sun B; Wu S; Zhao X
    Neurol Res; 2013 Jun; 35(5):505-11. PubMed ID: 23594748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Hsu WH; Lai CW; Chen SC; Chiou HC; Hsiao PJ; Shin SJ; Lee MY
    Endocr Pract; 2019 Sep; 25(9):918-925. PubMed ID: 31070951
    [No Abstract]   [Full Text] [Related]  

  • 40. Low high-density lipoprotein cholesterol as the possible risk factor for stroke.
    Demarin V; Lisak M; Morović S; Cengić T
    Acta Clin Croat; 2010 Dec; 49(4):429-39. PubMed ID: 21830454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.